Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in Türkiye [0.03%]
土耳其医学肿瘤学家与国际指南和国家报销之间的平衡：一项调查的见解
Ozgur Tanriverdi,Melek Ozdemir,Emre Hafizoglu et al.
Ozgur Tanriverdi et al.
Background: This study explores Turkish medical oncologists' perceptions of integrating international treatment guidelines with national reimbursement policies, considering local legal, economic, and healthcare constraint...
Cost-effectiveness of blood-based colorectal cancer screening - a simulation model incorporating real-world longitudinal adherence [0.03%]
基于血液的大肠癌筛查的成本效益研究——包含现实世界纵向依从性的模拟模型
Elifnur Yay Donderici,Shaun P Forbes,Nicole J Zhang et al.
Elifnur Yay Donderici et al.
Objectives: Although U.S. Preventive Services Task Force (USPSTF) recommended CRC screenings are effective; patient reluctance reduces adherence. Most cost-effectiveness models assume perfect adherence, yet one-third of e...
Preferences of nurses in the United Kingdom for attributes of pediatric hexavalent vaccines: a discrete-choice experiment [0.03%]
英国护士对儿童六联疫苗属性的偏好：一种离散选择试验
Christine Poulos,Tomas Marcek,Phani Chintakayala et al.
Christine Poulos et al.
Background: We evaluated UK nurses' preferences for pediatric hexavalent vaccine attributes. Research design and methods: In a discrete...
Budget Impact of low-dose computed tomography Screening for Lung Cancer in Argentina [0.03%]
低剂量螺旋计算机断层扫描筛查肺癌在阿根廷的预算影响分析
Constanza Silvestrini,Lucas Perelli,Andrea Alcaraz et al.
Constanza Silvestrini et al.
Background: Lung cancer (LC) is a leading cause of cancer mortality in Argentina. Low-dose computed tomography (LDCT) had demonstrated higher efficacy than chest radiography as a screening method for early detection and r...
How unprofessional behaviors between healthcare staff threaten patient care and safety [0.03%]
医务人员之间不专业行为的危害：影响病人安全与护理质量
Justin Aunger,Jill Maben,Johanna Westbrook
Justin Aunger
Introduction: Unprofessional behaviors (UB) such as bullying and incivility among healthcare staff are a significant and pervasive issue, impacting staff wellbeing, and patient safety and experiences of care. Despite its ...
Diabetes disparities in diabetes health care access and outcomes during the Covid-19 Pandemic in the United States [0.03%]
美国糖尿病患者在新冠大流行期间的糖尿病医疗可及性和结果差异性
Lixian Zhong,Yanlei Ma,Yelena Ionova et al.
Lixian Zhong et al.
Objectives: To investigate the impact of COVID-19 on hospitalization and consequent diabetes-related complications in patients with type 2 diabetes mellitus (diabetes). ...
A perspective on the use of patient-reported experience and patient-reported outcome measures in ambulatory healthcare [0.03%]
从患者角度出发：门诊治疗期间应用患者体验和患者结果评估指标的现状及前景展望
Ron D Hays,Denise D Quigley
Ron D Hays
Introduction: Patient-reported experience measures (PREMs) are patient reports about their healthcare, whereas patient-reported outcome measures (PROMs) are reports about their functioning and well-being regarding physica...
Cost-effectiveness analysis of trastuzumab emtansine for second-line treatment of HER2+ advanced breast cancer in Singapore [0.03%]
赫赛莱二线治疗HER2阳性晚期乳腺癌的卫生经济学分析
Wei Han Melvin Wong,Raymond Ng,Mohamed Ismail Abdul Aziz et al.
Wei Han Melvin Wong et al.
Objective: To evaluate the cost-effectiveness of trastuzumab emtansine (T-DM1) compared to both lapatinib plus capecitabine (lapcap) and trastuzumab plus capecitabine (trascap) for treating human epidermal growth factor 2...
Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England's national institute of health and care excellence [0.03%]
英国全民健康与护理卓越研究所治疗决策中利益攸关方意见的价值属性分析：先进疗法药品准入案例
Nermina Ferizovic,Ruth Plackett,Caroline S Clarke et al.
Nermina Ferizovic et al.
Objectives: Advanced therapy medicinal products (ATMPs) are transformative healthcare interventions, however, there has been limited research exploring their value. The objective of this study was to conduct a thematic an...
Methodological standards for comparative effectiveness research: considerations for evidentiary review for medicare drug price negotiation [0.03%]
医保药物价格谈判的证据审查效果研究方法标准考虑因素
Riddhi Doshi,Victoria Divino,Luke Greenwalt et al.
Riddhi Doshi et al.
Introduction: The 2022 Inflation Reduction Act (IRA) is expected to result in lower drug prices for Medicare beneficiaries in the United States (US). The Centers for Medicare & Medicaid Services (CMS) released the most re...